pralidoxime and Heart-Arrest

pralidoxime has been researched along with Heart-Arrest* in 5 studies

Other Studies

5 other study(ies) available for pralidoxime and Heart-Arrest

ArticleYear
Pralidoxime administered during cardiopulmonary resuscitation facilitates successful resuscitation in a pig model of cardiac arrest.
    Clinical and experimental pharmacology & physiology, 2020, Volume: 47, Issue:2

    Pralidoxime is a common antidote for organophosphate poisoning; however, studies have also reported pralidoxime's pressor effect, which may facilitate the restoration of spontaneous circulation (ROSC) after cardiac arrest by improving coronary perfusion pressure (CPP). We investigated the immediate cardiovascular effects of pralidoxime in anaesthetised normal rats and the effects of pralidoxime administration during cardiopulmonary resuscitation (CPR) in a pig model of cardiac arrest. To evaluate the immediate cardiovascular effects of pralidoxime, seven anaesthetised normal rats received saline or pralidoxime (20 mg/kg) in a randomised crossover design, and the responses were determined using the conductance catheter technique. To evaluate the effects of pralidoxime administration during CPR, 22 pigs randomly received either 80 mg/kg of pralidoxime or an equivalent volume of saline during CPR. In the rats, pralidoxime significantly increased arterial pressure than saline (P = .044). The peak effect on arterial pressure was observed in the first minute. In a pig model of cardiac arrest, CPP during CPR was higher in the pralidoxime group than in the control group (P = .002). ROSC was attained in three animals (27.3%) in the control group and nine animals (81.8%) in the pralidoxime group (P = .010). Three animals (27.3%) in the control group and eight animals (72.2%) in the pralidoxime group survived the 6-hour period (P = .033). In conclusion, pralidoxime had a rapid onset of pressor effect. Pralidoxime administered during CPR led to significantly higher rates of ROSC and 6-hour survival by improving CPP in a pig model.

    Topics: Animals; Antidotes; Blood Pressure; Cardiopulmonary Resuscitation; Cross-Over Studies; Disease Models, Animal; Heart Arrest; Heart Rate; Pralidoxime Compounds; Prospective Studies; Rats; Rats, Wistar; Swine

2020
Effects of Different Doses of Pralidoxime Administered During Cardiopulmonary Resuscitation and the Role of α-Adrenergic Receptors in Its Pressor Action.
    Journal of the American Heart Association, 2020, 03-03, Volume: 9, Issue:5

    Topics: Adrenergic alpha-Agonists; Animals; Blood Pressure; Cardiopulmonary Resuscitation; Cholinesterase Reactivators; Coronary Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Epinephrine; Heart Arrest; Pralidoxime Compounds; Rats; Rats, Wistar; Swine

2020
Pralidoxime-Induced Potentiation of the Pressor Effect of Adrenaline and Hastened Successful Resuscitation by Pralidoxime in a Porcine Cardiac Arrest Model.
    Cardiovascular drugs and therapy, 2020, Volume: 34, Issue:5

    Pralidoxime potentiated the pressor effect of adrenaline and facilitated restoration of spontaneous circulation (ROSC) after prolonged cardiac arrest. In this study, we hypothesised that pralidoxime would hasten ROSC in a model with a short duration of untreated ventricular fibrillation (VF). We also hypothesised that potentiation of the pressor effect of adrenaline by pralidoxime would not be accompanied by worsening of the adverse effects of adrenaline.. After 5 min of VF, 20 pigs randomly received either pralidoxime (40 mg/kg) or saline, in combination with adrenaline, during cardiopulmonary resuscitation (CPR). Coronary perfusion pressure (CPP) during CPR, and ease of resuscitation were compared between the groups. Additionally, haemodynamic data, severity of ventricular arrhythmias, and cerebral microcirculation were measured during the 1-h post-resuscitation period. Cerebral microcirculatory blood flow and brain tissue oxygen tension (PbtO. All animals achieved ROSC. The pralidoxime group had higher CPP during CPR (P = 0.014) and required a shorter duration of CPR (P = 0.024) and smaller number of adrenaline doses (P = 0.024). During the post-resuscitation period, heart rate increased over time in the control group, and decreased steadily in the pralidoxime group. No inter-group differences were observed in the incidences of ventricular arrhythmias, cerebral microcirculatory blood flow, and PbtO. Pralidoxime improved CPP and hastened ROSC in a model with a short duration of untreated VF. The potentiation of the pressor effect of adrenaline was not accompanied by the worsening of the adverse effects of adrenaline.

    Topics: Adrenergic Agonists; Animals; Cardiopulmonary Resuscitation; Disease Models, Animal; Epinephrine; Heart Arrest; Hemodynamics; Pralidoxime Compounds; Recovery of Function; Sus scrofa; Time Factors; Ventricular Fibrillation

2020
Respiratory arrest caused by accidental rapid pralidoxime infusion.
    Clinical toxicology (Philadelphia, Pa.), 2015, Volume: 53, Issue:4

    Topics: Adult; Cholinesterase Reactivators; Diazinon; Heart Arrest; Humans; Infusions, Intravenous; Insecticides; Male; Medical Errors; Organophosphate Poisoning; Pralidoxime Compounds; Respiration, Artificial

2015
Repeated asystole following PAM in organophosphate self-poisoning.
    Anaesthesia and intensive care, 1986, Volume: 14, Issue:4

    Topics: Arrhythmias, Cardiac; Heart Arrest; Humans; Insecticides; Male; Middle Aged; Organophosphorus Compounds; Pralidoxime Compounds

1986